Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.46M Sell
6,784
-621
-8% -$213K 0.17% 143
2026
Q1
$2.61M Sell
7,405
-9
-0.1% -$3.21K 0.2% 122
2025
Q4
$2.43M Buy
7,414
+568
+8% +$180K 0.18% 124
2025
Q3
$1.93M Sell
6,846
-589
-8% -$171K 0.15% 156
2025
Q2
$2.08M Buy
7,435
+761
+11% +$216K 0.17% 146
2025
Q1
$2.08M Buy
6,674
+6,668
+111,133% +$1.97M 0.18% 120
2024
Q4
$1.67K Sell
6
-6,466
-100% -$1.92M 0.15% 150
2024
Q3
$2.08M Sell
6,472
-207
-3% -$67.7K 0.18% 119
2024
Q2
$2.09M Buy
6,679
+443
+7% +$130K 0.19% 113
2024
Q1
$1.77M Sell
6,236
-61
-1% -$17.8K 0.17% 122
2023
Q4
$1.81M Sell
6,297
-436
-6% -$119K 0.18% 114
2023
Q3
$1.81M Buy
+6,733
New +$1.68M 0.2% 106

Other funds holding AMGN

NBC Securities's AMGN Position: Q2 2026 in Review

NBC Securities reduced its Amgen (AMGN) stake by 8.4% in Q2 2026, selling an estimated $213K and leaving 6,784 shares worth $2.46M. The position accounts for 0.17% of the portfolio, ranked #143.

NBC Securities first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.61M in Q1 2026. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • NBC Securities held 6,784 shares of Amgen worth $2.46M as of Q2 2026.
  • NBC Securities sold 621 Amgen shares in Q2 2026, an estimated $213K.
  • Amgen made up 0.17% of NBC Securities's portfolio in Q2 2026, its #143 holding.
  • NBC Securities first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Amgen position peaked at $2.61M in Q1 2026.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.